Press Releases
While COVID-19 infected patients should be treated with standard anticoagulation therapies, such as blood thinning medication, a new study by researchers at the George Washington University shows that anticoagulating patients at higher doses, without traditional medical indications to do so, may be…
Third-year MD student King John Pascual and mentor Ali Pourmand, MD, from SMHS are presenting findings at the American College of Emergency Physicians on the role of Google searches during the early phase of the pandemic in the U.S.
The George Washington University, in partnership with several community organizations, is providing free flu shots to people living in Ward 7 and Ward 8 and other medically underserved parts of Washington, D.C.
The National Institutes of Health has awarded $1.6 million to researchers at SMHS for research on hormonal control of HIV latency.
Building on its widely recognized KastleSafeSpaces health safety and security platform, Kastle Systems announced today it is partnering with a multidisciplinary team from GW to provide safe and efficient returns to the workplace for their tenants and clients in the wake of the coronavirus pandemic.
The retrospective study from a team at GW found that spironolactone may be safe to treat female pattern hair loss in breast cancer survivors.
Investigators at SMHS received a $1.2 million grant from Wellcome Trust to produce a controlled human hookworm infection model and establish a hookworm vaccine challenge model for two of the most advanced hookworm vaccine candidate antigens in endemic areas.
Alberto Bosque, PhD, MBA, assistant professor of microbiology, immunology, and tropical medicine, and his research team published in PLOS Pathogens finding a multiple sclerosis drug may be used to block HIV infection and reduce the latent reservoir.
Alejandro Villagra, PhD, assistant professor of biochemistry and molecular medicine, and his research team published a new study in Cancer Research, finding the genetic modifier HDAC6 controls tumor growth and halts metastasis in triple-negative breast cancer in vivo.
Juan Reyes, MD, and Shant Ayanian, MD, both assistant professors of medicine, published research in the journal Future Medicine, finding five biomarkers associated with higher odds of clinical deterioration and death in COVID-19 patients.